Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxepin vs Diphenhydramine for Urticaria in ED
NCT05115136Phase 3Unknown
- Sponsor
- Upstate Medical University
- Start
- May 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doxepin in urticaria, sponsored by Upstate Medical University. Status: unknown.
02
Drugs
doxepin
03
Conditions
urticaria
Beyond the preview
Go deeper on NCT05115136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05115136.